甲壳质酶蛋白-40在肾结核和肾肿瘤患者中的表达差异及临床意义

Abstract
Figure/Table
References (25)
Related Citation (15)

Download: PDF (410 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To analysis the levels and differences of chitinase protein-40 (YKL-40) in serum and urine of patients with renal tuberculosis and renal tumors. Methods From May 2016 to May 2019, 100 patients with renal tuberculosis admitted to the First Affiliated Hospital of Hebei North University (hereinafter referred to as “our hospital”) were selected as renal tuberculosis group and 50 patients with renal tumor as renal tumor group. Meanwhile, 100 examinees who came to our hospital for physical examination at the same time were selected as the reference group, and YKL-40 levels in serum and urine of three groups of patients were detected by enzyme-linked immunosorbent assay. At the same time, the normal tissues around the lesion were collected and made into paraffin samples. The expression of YKL-40 in the lesion was observed by immunohistochemistry. The clinical data of all study samples were retrospectively analyzed. Compared the difference of YKL-40 levels in urine and serum between patients with renal tuberculosis and renal tumor and normal persons, and observed the expression of YKL-40 in pathological tissues and surrounding normal tissues of patients with renal tuberculosis and renal tumor. Results The level of YKL-40 in serum and urine samples of reference group was lower than that of renal tuberculosis group and renal tumor group (P ＜ 0.05). There was no significant difference in serum and urine YKL-40 levels between renal tuberculosis group and renal tumor group (P ＞ 0.05). The level of YKL-40 in pathological tissues of patients with renal tuberculosis and renal tumor was significantly higher than that in surrounding normal tissues (P ＜ 0.05). Conclusion The level of YKL-40 in urine and serum of patients with renal tuberculosis and renal tumor is significantly increased, which can be used as the basis for the preliminary diagnosis of the disease. However, in order to improve the diagnostic accuracy, it should be combined with other laboratory diagnostic criteria.

Key words： Renal tuberculosis Renal tumor Hematuria Anemia Chitinase protein-40

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Xiujun AN Haixia YANG Jiaxin CHEN Huai’an

Cite this article:

LI Xiujun AN Haixia YANG Jiaxin CHEN Huai’an. Expression difference and clinical significance of chitinase protein-40 in patients with renal tuberculosis and renal tumor[J]. 中国医药导报, 2021, 18(6): 95-98.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2021/V18/I6/95

[1] 黎灿强，杨毅，何伟成，等.完全性后腹腔镜下肾输尿管全长切除术治疗肾结核的临床体会[J].中国内镜杂志，2017，23（4）：106-109.
[2] Rafiei N，Williams J，Mulley WR，et al. Mycobacterium tuberculosis：Active disease and latent infection in a renal transplant cohort [J]. Nephrology （Carlton），2019，24（5）：569-574.
[3] Plachouri KM，Georgiou S. Special aspects of biologics treatment in psoriasis：management in pregnancy，lactation，surgery，renal impairment，hepatitis and tuberculosis [J]. J Dermatolog Treat，2019，30（7）：668-673.
[4] 王栋，曹娜，唐桂林，等.肾脏肿瘤患者CT灌注参数与肾功能生化指标和肿瘤标志物的相关性研究[J].河北医药，2018，40（11）：1634-1637.
[5] 栗恒，李宏彬，夏钢，等.传统开放性肾癌根治性切除术与后腹腔镜肾癌根治性切除术对肾癌患者的临床疗效及对肾功能的影响[J].癌症进展，2019，17（14）：1679-1682.
[6] 王成军，邱邦东.恩替卡韦联合聚乙二醇干扰素α2a治疗乙型病毒性肝炎的效果及对患者血清YKL-40、CEA水平的影响[J].海南医学，2019，30（20）：2608-2611.
[7] 葛均波，徐永健.内科学[M].8版.北京：人民卫生出版社，2013，227-255，741-742.
[8] 孙明，杨侃.内科治疗学[M].3版.北京：人民卫生出版社，2010：882-884.
[9] 于瑞淼.探讨YKL-40在肝硬变中的诊断价值及其与肝硬变患者肝功能和现有肝纤维化指标的相关性[J].西北国防医学杂志，2017，38（9）：579-582.
[10] 靳书滨，李强，焦建军.头颈部皮肤鳞状细胞癌手术切缘HE染色及基质金属蛋白酶1表达与术后复发的关系[J].中国医刊，2019，54（11）：1238-1240.
[11] 朱俊，丁莹，王世清，等.围手术期应用乌司他丁治疗对肝细胞癌患者肝切除术后外周血Th22细胞百分比和血浆白细胞介素-22的影响[J].实用肝脏病杂志，2019， 22（5）：720-723.
[12] 唐嘉励，段东，张辉.99Tcm-MIBI SPECT/CT显像及平面显像半定量分析对原发性甲状旁腺功能亢进症的诊断价值[J].中华内分泌外科杂志，2019，13（1）：17-21.
[13] Okada RC，Barry PM，Skarbinski J，et al. Epidemiology，detection，and management of tuberculosis among end-stage renal disease patients [J]. Infect Control Hosp Epidemiol，2018，39（11）：1367-1374.
[14] Kumar A Dangi AD，Mukha RP，et al. Can kidneys be saved in patients with urinary tuberculosis? A study in the era of modern chemotherapy and surgical armamentarium [J]. Int J Urol，2019，26（5）：551-557.
[15] 刘振坤，乔明涛，安瑞肖，等.PCT、YKL-40、sICAM-1、TRAIL和IP-10联合检测在慢性阻塞性肺疾病气道炎症中的诊断意义[J].实用医院临床杂志，2019，16（1）：176-180.
[16] 于志暄，王云枝.YKL-40和MPV在2型糖尿病早期肾病的临床价值[J].中华临床医师杂志：电子版，2017，11（7）：1110-1113.
[17] 陈怀安，刘硕，王哲，等.YKL-40在肾结核患者中的表达及临床意义[J].临床泌尿外科杂志，2019，34（12）：953-956.
[18] 侯永强，王新征.血清YKL-40蛋白水平与肝硬化患者肝功能、肝纤维化的相关性及作用机制[J].中西医结合肝病杂志，2019，29（5）：427-429.
[19] 陈怀安，李秀君，刘硕，等.甲壳质酶蛋白40联合诊断肾结核的临床意义[J].中华实验外科杂志，2019，36（7）：1174.
[20] 代海涛，程帆，刘昌茂，等.肾细胞癌中人软骨糖蛋白39在外周血及组织的表达[J].中华实验外科杂志，2020， 37（1）：166-168.
[21] 陈烨，朱春玲.几丁质酶样蛋白YKL-40与肾间质纤维化[J].医药前沿，2015，5（8）：7-9.
[22] 陈怀安，刘硕，李秀君，等.甲壳质酶蛋白40对肾结核的诊断效能及关系研究[J].中国现代医学杂志，2019， 29（14）：110-113.
[23] 罗逊，刘曼婷，李世瑶，等.血清YKL-40、FABP4水平与腹膜透析患者容量超负荷的关系[J].山东医药，2018， 58（41）：30-33.
[24] 朱智勇，吕永聪.超声引导下经皮肾组织穿刺活检术对肾脏疾病的应用探讨[J].中国医药科学，2019，9（7）：137-139.
[25] 邓虔玉，李惠施，叶佩仪，等.缩短卧床时间对经皮肾穿刺活检术后患者舒适性和安全性的影响[J].山西医药杂志，2018，47（15）：1855-1857.